Global Large Volume Parenteral Lvp Market Growth Analysis 2024, Forecast To 2033
8 Mar, 2024
The large volume parenteral (LVP) market has seen strong growth, increasing from $11.42 billion in 2023 to $12.44 billion in 2024, with a CAGR of 9.0%. Factors such as chronic disease prevalence and healthcare infrastructure expansion have contributed to this growth. Projections indicate further expansion to $17.35 billion by 2028, with a CAGR of 8.7%, driven by demand for biologics and personalized medicine. Trends include technological advancements, single-use technologies, and 3D printing applications.
Global Large Volume Parenteral LVP Market Key Driver
The growing prevalence of chronic diseases is set to fuel the growth of the large-volume parenteral market. With projections suggesting a 99.5% increase in individuals aged 50 years and older with at least one chronic illness in the US by 2050, rising from 71.522 million in 2020 to 142.66 million, there's a growing need for effective treatments. Large-volume parenteral solutions provide essential nutrients directly into the bloodstream, bypassing the digestive system, making them vital for patients with chronic illnesses requiring proper nutrition. Consequently, the increasing prevalence of chronic diseases is a significant driver for the large-volume parenteral market.
Get A Free Sample Of The Global Large Volume Parenteral LVP Market ReportGlobal Large Volume Parenteral LVP Market Segments
The large volume parenteral (lvp) market covered in this report is segmented –
1) Type:Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP
2) Volume:100 ML - 250 ML, 250 ML - 500 ML, 500 ML - 1000 ML, 1000 ML -2000 ML, 2000 And More
3) Application:Basic Infusion, Therapeutics Infusion, Nutritious Infusion
4) End-User:Hospital, Medical Centers, Other End Users
By Geography: The countries covered in the large volume parenteral (lvp) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the large volume parenteral (LVP) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Large Volume Parenteral LVP Industry Players
Pfizer Inc.; Fresenius Kabi AG; Abbott Laboratories Inc.; Becton Dickinson and Company; Otsuka Holdings Co Ltd.; Baxter International Inc.; B Braun Melsungen AG; Grifols SA; Cipla Limited; ICU Medical Inc.; Biocon Limited; Sichuan Kelun Pharmaceutical Co. Ltd.; Alembic Pharmaceuticals Limited; Cadila Healthcare Ltd.; Gland Pharma Limited; Akums Drugs & Pharmaceuticals Ltd.; Beximco Pharmaceutical Ltd.; Nelson Laboratories LLC; Taj Pharmaceuticals Limited; Albert David Ltd.; Amanta Healthcare Ltd.; Unique Pharmaceutical Laboratories Ltd.; Ahlcon Parenterals India Ltd; Parenteral Drugs Limited; Abaris Healthcare Pvt. Ltd.; BML Parenteral Drugs; Denis Chem Lab Ltd; Pentagon Labs Ltd.; DJ Labs Pvt Ltd.; Higgs Healthcare.
Get The Full Global Large Volume Parenteral LVP Market Report
Large Volume Parenteral LVP Market Overview
Large volume parenteral (LVP) refers to sterile intravenous solutions of a volume of 100 ml or more that are terminally sterilized by heat. They are used for intravenous infusions to administer hydration, nourishment, and medicine.